02 Nov 2021
JPND launches call for expert working groups on the impact of Covid-19 on neurodegenerative disease research
On 1 November 2021, the EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative launched a call for expert working groups on the impact of Covid-19 on neurodegenerative disease research.
Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Globally, there are estimated to be 50 million people with Alzheimer’s disease and related disorders, the most common group of neurodegenerative diseases. The EU Joint Programme – Neurodegenerative Disease Research (JPND) has been established to better coordinate research efforts across countries and disciplines to more rapidly find causes, develop cures and identify better ways to care for people with neurodegenerative diseases. To identify research priorities, the JPND Research and Innovation Strategy, published in 2019, provides a framework for future investment.
The aim of this call is to establish a number of ambitious, innovative, multi-disciplinary and multinational expert Working Groups to discuss research strategies that concern the impact of COVID-19 on the development and progression of neurodegenerative disease as well as on the care of patients with neurodegenerative diseases.
More information can be found here: